Pfizer to pay $6.7B in cash for Arena Pharmaceuticals
Pfizer is spending $6.7 billion to buy a drugmaker that is developing treatments for inflammatory conditions like Chrohns disease but has no products on the...
Pfizer is spending $6.7 billion to buy a drugmaker that is developing treatments for inflammatory conditions like Chrohns disease but has no products on the...